• Thu, March 31, 2022

by: WOPRAI

Marc Goodman Maintained (AMLX) at Buy with Decreased Target to $31 on, Mar 31st, 2022

by: WOPRAI

Paul Sankey Upgraded (APA) to Strong Buy and Increased Target to $56 on, Mar 31st, 2022

by: WOPRAI

Do Kim Initiated (AFMD) at Buy and Held Target at $70 on, Mar 31st, 2022

by: WOPRAI

Mark Devries Maintained (AER) at Buy with Decreased Target to $72 on, Mar 31st, 2022

by: WOPRAI

Christopher Stathoulopoulos Maintained (AER) at Buy with Decreased Target to $75 on, Mar 31st, 2022

by: WOPRAI

Moshe Orenbuch Maintained (AER) at Buy with Decreased Target to $70 on, Mar 31st, 2022

by: WOPRAI

Vincent Ciantic Maintained (AER) at Buy with Decreased Target to $74 on, Mar 31st, 2022

by: WOPRAI

Steven Delaney Maintained (ACRE) at Buy with Increased Target to $17 on, Mar 31st, 2022

by: WOPRAI

David Dai Initiated (ACET) at Buy and Held Target at $28 on, Mar 31st, 2022

by: WOPRAI

Amit Daryanani Maintained (AAPL) at Buy and Held Target at $210 on, Mar 31st, 2022

by: WOPRAI

Christopher Raymond Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022

by: WOPRAI

Difei Yang Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022

by: WOPRAI

Serge Belanger Downgraded (AKBA) to Hold on, Mar 31st, 2022

by: WOPRAI

Ed Arce Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022

by: WOPRAI

Whit Mayo Maintained (AGL) at Buy with Increased Target to $33 on, Mar 31st, 2022

by: WOPRAI

Peter Sazel Initiated (SNOW) at Hold and Held Target at $240 on, Mar 31st, 2022

by: WOPRAI

Derek Johnston Maintained (SPG) at Strong Buy with Decreased Target to $173 on, Mar 31st, 2022

by: WOPRAI

Javier Martinez Downgraded (SQM) to Sell and Increased Target to $70 on, Mar 31st, 2022

by: WOPRAI

Steven Pizzella Maintained (SRAD) at Strong Buy with Decreased Target to $20 on, Mar 31st, 2022

by: WOPRAI

Michael Graham Maintained (SRAD) at Strong Buy with Decreased Target to $25 on, Mar 31st, 2022

by: WOPRAI

Stephen Laws Upgraded (STWD) to Strong Buy and Held Target at $32 on, Mar 31st, 2022

by: WOPRAI

Katy Huberty Maintained (STX) at Hold with Decreased Target to $99 on, Mar 31st, 2022

by: WOPRAI

Steven Chubak Downgraded (STT) to Hold and Held Target at $101 on, Mar 31st, 2022

by: WOPRAI

Matthew Bouley Downgraded (TMHC) to Hold and Decreased Target to $33 on, Mar 31st, 2022

by: WOPRAI

Marcelo Santos Upgraded (TIGO) to Buy on, Mar 31st, 2022

by: WOPRAI

Ben Hendrix Maintained (AVAH) at Buy with Decreased Target to $9 on, Mar 31st, 2022

by: WOPRAI

John Ransom Maintained (AVAH) at Strong Buy with Decreased Target to $8 on, Mar 31st, 2022

by: WOPRAI

Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022

by: WOPRAI

Michael Walkley Maintained (BB) at Hold and Held Target at $7 on, Mar 31st, 2022

by: WOPRAI

Blayne Curtis Downgraded (AMD) to Hold and Decreased Target to $115 on, Mar 31st, 2022

by: WOPRAI

Evan Seigerman Maintained (CADL) at Buy with Decreased Target to $12 on, Mar 31st, 2022

by: WOPRAI

Brent Bracelin Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022

by: WOPRAI

Scott Berg Maintained (BRZE) at Strong Buy with Decreased Target to $70 on, Mar 31st, 2022

by: WOPRAI

Brian Schwartz Maintained (BRZE) at Buy with Decreased Target to $60 on, Mar 31st, 2022

by: WOPRAI

Brian Peterson Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022

by: WOPRAI

David Hynes Maintained (BRZE) at Strong Buy with Decreased Target to $60 on, Mar 31st, 2022

by: WOPRAI

Derek Johnston Maintained (BRX) at Hold with Increased Target to $28 on, Mar 31st, 2022

by: WOPRAI

Stephen Powers Initiated (BRCC) at Hold and Held Target at $19 on, Mar 31st, 2022

by: WOPRAI

Devin Dodge Maintained (BIP) at Buy with Increased Target to $47 on, Mar 31st, 2022

by: WOPRAI

Roger Read Upgraded (BKR) to Buy and Held Target at $43 on, Mar 31st, 2022

by: WOPRAI

Steven Chubak Downgraded (BK) to Hold and Held Target at $55 on, Mar 31st, 2022

by: WOPRAI

Alexander Blostein Maintained (BK) at Hold with Decreased Target to $60 on, Mar 31st, 2022

by: WOPRAI

Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $9 on, Mar 31st, 2022

by: WOPRAI

Heiko Ihle Maintained (AREC) at Strong Buy with Increased Target to $4.5 on, Mar 31st, 2022

by: WOPRAI

Joseph Feldman Maintained (ARHS) at Buy with Increased Target to $12 on, Mar 31st, 2022

by: WOPRAI

Rayna Kumar Initiated (WU) at Hold and Held Target at $19 on, Mar 31st, 2022

by: WOPRAI

Do Kim Initiated (TVTX) at Buy and Held Target at $42 on, Mar 31st, 2022

by: WOPRAI

Jim Duffy Initiated (WRBY) at Hold and Held Target at $36 on, Mar 31st, 2022

Ed Arce Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022

Ed Arce of HC Wainwright & Co., Downgraded "Akebia Therapeutics, Inc." (AKBA) to Hold and Decreased Target from $10 to $2 on, Mar 31st, 2022.

Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍